Glaukos Corporation (GKOS) Financials
Key financial figures for Glaukos Corporation (Q3 2026).
Glaukos reported record Q3 2026 net sales of $211.0 million, up 58% year over year, a GAAP profit of $0.03 per diluted share, and raised 2026 net sales guidance to $775 million to $785 million. Sales: Net sales were $211.0 million, up 58% reported and in constant currency from $133.5 million a year earlier and up from $185.6 million in Q2 2026. Drivers: U.S. Glaucoma net sales were $118.6 million (+47%), with the 10-Q citing higher iDose TR volume. Corneal Health net sales were $59.0 million (+154%), led by U.S. Epioxa as customers moved from Photrexa. International Glaucoma was $33.4 million (+13%). Profitability: GAAP gross margin was about 85% (non-GAAP about 88%, 87.7% in the reconciliation table). On the outlook: 2026 net sales of $775 million to $785 million (raised from $680 million to $700 million), based on the latest foreign currency exchange rates; preliminary 2027 net sales of $1 billion. Figures are for Q3 2026, as Glaukos Corporation reported them.
- Revenue
- $211M
- Net Income
- $2M
- EPS
- $0.03
- Total Assets
- $980M
- Operating Cash Flow
- $39M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $211M | $2M | $0.03 | 0.39% | $36M |
| Q2 FY2026 | $186M | -$18M | -$0.31 | -9.3% | $12M |
| Q1 FY2026 | $151M | -$20M | -$0.34 | -13.19% | -$16M |
| Q4 FY2025 | $143M | -$134M | -$2.32 | -18.87% | $4M |
| Q3 FY2025 | $134M | -$16M | -$0.28 | -12.26% | -$12M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $507M | -$188M | -$3.28 | -17.09% | -$54M |
| FY2024 | $383M | -$146M | -$2.77 | -31.91% | -$68M |
| FY2023 | $315M | -$135M | -$2.78 | -40.89% | -$78M |
Frequently asked questions
What was Glaukos Corporation's revenue last quarter?
Glaukos Corporation reported revenue of $211.0 million for Q3 FY2026, up 58.0% from the same period a year earlier.
Is Glaukos Corporation profitable?
Yes. Glaukos Corporation reported net income of $2.0 million for Q3 FY2026, a net margin of 0.96% on revenue.
How has Glaukos Corporation's margin trended?
Operating margin was 0.39% in Q3 FY2026, compared with -12.26% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Glaukos Corporation generate?
Glaukos Corporation generated free cash flow of $36.5 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Glaukos Corporation on SentiSense, with up to forty quarters and twenty fiscal years of history.